Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations.

Jahangiri A, Wagner J, Tran MT, Miller LM, Tom MW, Kunwar S, Blevins L Jr, Aghi MK.

J Neurosurg. 2013 Dec;119(6):1478-83. doi: 10.3171/2013.7.JNS13273. Epub 2013 Aug 23.

PMID:
23971964
2.

Delayed postoperative hyponatremia after transsphenoidal surgery: prevalence and associated factors.

Hussain NS, Piper M, Ludlam WG, Ludlam WH, Fuller CJ, Mayberg MR.

J Neurosurg. 2013 Dec;119(6):1453-60. doi: 10.3171/2013.8.JNS13411. Epub 2013 Sep 20.

PMID:
24053496
3.

Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations.

Jahangiri A, Wagner J, Han SW, Zygourakis CC, Han SJ, Tran MT, Miller LM, Tom MW, Kunwar S, Blevins LS Jr, Aghi MK.

J Neurosurg. 2014 Jul;121(1):67-74. doi: 10.3171/2014.3.JNS131532. Epub 2014 May 16.

PMID:
24834943
4.

Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.

Chen S, Zhao JJ, Tong NW, Guo XH, Qiu MC, Yang GY, Liu ZM, Ma JH, Zhang ZW, Gu F.

J Clin Pharmacol. 2014 Dec;54(12):1362-7. doi: 10.1002/jcph.342.

PMID:
24906029
5.

Use of intravenous conivaptan in neurosurgical patients with hyponatremia from syndrome of inappropriate antidiuretic hormone secretion.

Potts MB, DeGiacomo AF, Deragopian L, Blevins LS Jr.

Neurosurgery. 2011 Aug;69(2):268-73. doi: DOI: 10.1227/NEU.0b013e318218c78f.

PMID:
21792136
6.

Delayed onset of hyponatremia after transsphenoidal surgery for pituitary adenomas.

Taylor SL, Tyrrell JB, Wilson CB.

Neurosurgery. 1995 Oct;37(4):649-53; discussion 653-4. Review.

PMID:
8559292
7.

Use of conivaptan for management of hyponatremia following surgery for Cushing's disease.

Breshears JD, Jiang B, Rowland NC, Kunwar S, Blevins LS.

Clin Neurol Neurosurg. 2013 Nov;115(11):2358-61. doi: 10.1016/j.clineuro.2013.08.019. Epub 2013 Aug 27.

PMID:
24041963
8.
9.

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C; SALT Investigators.

N Engl J Med. 2006 Nov 16;355(20):2099-112. Epub 2006 Nov 14.

10.

Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion in adult spinal surgery.

Callewart CC, Minchew JT, Kanim LE, Tsai YC, Salehmoghaddam S, Dawson EG, Delamarter RB.

Spine (Phila Pa 1976). 1994 Aug 1;19(15):1674-9.

PMID:
7973959
11.

Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.

Levine JP, Stelnicki E, Weiner HL, Bradley JP, McCarthy JG.

Plast Reconstr Surg. 2001 Nov;108(6):1501-8.

PMID:
11711918
12.

Hyponatremia after transsphenoidal surgery for hypothalamo-pituitary tumors.

Sata A, Hizuka N, Kawamata T, Hori T, Takano K.

Neuroendocrinology. 2006;83(2):117-22. Epub 2006 Jul 24.

PMID:
16864995
13.

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.

Verbalis JG, Greenberg A, Burst V, Haymann JP, Johannsson G, Peri A, Poch E, Chiodo JA 3rd, Dave J.

Am J Med. 2016 May;129(5):537.e9-537.e23. doi: 10.1016/j.amjmed.2015.11.005. Epub 2015 Nov 14.

PMID:
26584969
14.

[The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].

Rollino C, Balbiano R, Caramello P, Roccatello D.

G Ital Nefrol. 2013 Nov-Dec;30(6). pii: gin/30.6.8. Italian.

PMID:
24402662
15.

Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.

Murphy T, Dhar R, Diringer M.

Neurocrit Care. 2009;11(1):14-9. doi: 10.1007/s12028-008-9179-3. Epub 2009 Jan 4.

17.
18.

Tolvaptan for the management of syndrome of inappropriate antidiuretic hormone secretion: lessons learned in titration of dose.

Torres AC, Wickham EP, Biskobing DM.

Endocr Pract. 2011 Jul-Aug;17(4):e97-100. doi: 10.4158/EP10386.CR. Review.

19.

[Lower doses of tolvaptan in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion].

Sánchez Sobrino P, Fernández Catalina P, Lorenzo Solar M, Rego Iraeta A.

Med Clin (Barc). 2015 Aug 7;145(3):138-9. doi: 10.1016/j.medcli.2014.10.011. Epub 2014 Dec 24. Spanish. No abstract available.

PMID:
25543222
20.

Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.

Cárdenas A, Ginès P, Marotta P, Czerwiec F, Oyuang J, Guevara M, Afdhal NH.

J Hepatol. 2012 Mar;56(3):571-8. doi: 10.1016/j.jhep.2011.08.020. Epub 2011 Oct 23.

PMID:
22027579
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk